VBI Vaccines
VBIV
#10518
Rank
A$2.62 M
Marketcap
A$0.09159
Share price
0.00%
Change (1 day)
-90.46%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): A-$15.27

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is A-$14.22. In 2022 the company made an earnings per share (EPS) of A-$18.51 a decrease over its 2021 EPS that were of A-$11.36.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)A-$15.27
2022A-$18.5162.96%
2021A-$11.3628.57%
2020A-$8.84-54.35%
2019A-$19.36-52.58%
2018A-$40.8210.23%
2017A-$37.0314.29%
2016A-$32.40-62.8%
2015A-$87.1090.68%
2014A-$45.68-7.95%
2013A-$49.63-57.97%
2012A-$118.09-78%
2011A-$536.853151.47%
2010A-$16.5123.87%
2009A-$13.33-18.48%
2008A-$16.3512.08%
2007A-$14.59-49.47%
2006A-$28.87
2005N/A-100%
2004A-$12.8411.94%
2003A-$11.47-81.89%
2002A-$63.32196.44%
2001A-$21.3684.33%
2000A-$11.59-65.37%
1999A-$33.46-29.45%
1998A-$47.4329.61%
1997A-$36.59

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
A-$1.33-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
A-$5.15-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
A-$6.07-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA